Hepatitis C Inquiry 2017

APPG on Liver Health inquiry into hepatitis C elimination: Call for evidence

In May 2016, the UK Government joined 193 other member states at the 69th World Health Assembly in committing to eliminate viral hepatitis C globally by 2030. There has been a rise in the number of people accessing treatment for hepatitis C in England in recent years, but further increases in testing, diagnosis, referral and treatment will be required in order to achieve elimination by 2030.

The All Party Parliamentary Group (APPG) on Liver Health is launching an inquiry that seeks to support efforts towards elimination. As well as staging oral evidence sessions, the APPG is calling for written evidence from individuals and organisations to contribute their perspectives on how the elimination of hepatitis C can be achieved in England. On the basis of this evidence, a ‘blueprint for elimination’ will be produced, setting out some of the practical steps that can be taken to ensure a hepatitis C-free England.

The deadline for submissions is 27th October. Please submit all written evidence to aidan.rylatt@hepctrust.org.uk.

A limited number of audience places are also available for the oral evidence sessions taking place in October. Please contact aidan.rylatt@hepctrust.org.uk to secure your place. Please note there will be no opportunity for audience members to contribute to the session.

What information are we looking for?

In your submission, please address some or all of the following questions:

Prevention, testing & diagnosis

  • What further actions could be taken to prevent new hepatitis C infections?
  • What action could be taken to increase testing among:
    • People who inject drugs
    • People from South Asian and Eastern European communities
    • People who use image and performance enhancing drugs
    • People who may have been infected with hepatitis C through contaminated blood
    • Men who have sex with men
  • In which settings should testing be introduced or increased in order to find those who remain undiagnosed?
  • What action could be taken to diagnose people who used to inject drugs but no longer do so and are not in contact with substance misuse services?
  • What action could be taken to re-engage with people who have previously been diagnosed with hepatitis C but who have disengaged with the care pathway?

Referral & treatment

  • What action could be taken to increase the numbers of people referred to specialist services?
  • What barriers currently prevent people from engaging with specialist services following diagnosis?
  • What additional support is required in order to ensure that people engage with specialist services?
  • What is the impact of the NHS England ‘run rates’, specifying the number of people able to receive treatment in different local areas?
  • What action could be taken to make treatment as accessible as possible?
  • What steps can be taken to prevent reinfection?

Funding & elimination

  • What are your views on the feasibility of eliminating hepatitis C in England by 2030, based on current testing and treatment rates?
  • Do you have proposals for funding models that could facilitate the development of a ‘treat all’ approach to providing treatment?
  • Do you have any further comments on the steps required to eliminate hepatitis C?